Abivax (ABVX) released its Q2 2026 earnings results on September 21, 2026, after market close. The company reported an EPS of -1.47 EUR, missing the analyst estimate of -0.80 EUR by 83.5%. Revenue was reported at 1 million EUR. Following the release, the stock price decreased by 4.69%.
Generated automatically from our data — as of September 30, 2026
Key figures at a glance
Estimate (EPS): -0.80 EUR
Reported (EPS): -1.47 EUR
Price reaction: -4.7%
Frequently asked questions
Did Abivax beat or miss earnings-per-share expectations?
Abivax missed the analyst estimate of -0.80 EUR earnings per share (Q2 2026) by 83.5%, reporting only -1.47 EUR.
How did Abivax stock react to the earnings report?
Abivax stock fell 4.7% on the trading day following the release.
What was Abivax's revenue in Q2 2026?
Abivax reported revenue of 1M EUR in Q2 2026.